Pharma Journalist -

uniQure has reported encouraging early clinical results from its experimental gene therapy AMT-260, offering new hope for patients living with refractory mesial temporal lobe epilepsy…
Read More...

Boltz PBC, an applied artificial intelligence research company focused on biomolecular modeling, has announced a new collaboration with Takeda aimed at bringing advanced AI-driven tools…
Read More...

SK pharmteco has entered into a new strategic collaboration with the Orphan Therapeutics Accelerator (OTXL), a non-profit biotechnology organization focused on advancing stalled rare…
Read More...

The success of GLP-1 medicines has changed the way healthcare professionals view obesity and metabolic diseases. Over the past few years, drugs such as semaglutide and tirzepatide have…
Read More...

The pharmaceutical industry is entering a new chapter as artificial intelligence (AI) begins to play a larger role in drug discovery and development. What once seemed like a futuristic…
Read More...

Vedana Therapeutics has emerged from stealth mode with $46 million in Series A financing and ambitious plans to develop next-generation therapies for migraine prevention, targeting…
Read More...

LG AI Research and D&D Pharmatech have entered into a strategic partnership aimed at accelerating the development of next-generation oral peptide therapies, highlighting the growing…
Read More...

Jazz Pharmaceuticals and AbCellera have entered into a new research collaboration aimed at developing next-generation antibody-based treatments for gastrointestinal (GI) cancers and…
Read More...

Biogen has agreed to acquire private biotechnology company RayThera in a deal valued at up to $1 billion, strengthening the company's growing focus on immunology and expanding its…
Read More...

Insilico Medicine has announced a significant milestone in the development of its experimental drug candidate ISM8969, marking the first time the therapy has been administered to…
Read More...